FDA Approves Pomalyst for Multiple Myeloma
On February 8, 2013 the U.S. Food and Drug Administration approved a new drug to treat multiple myeloma. The drug, Pomalyst (pomalidomide) is approved for use in patients whose disease has progressed after being treated with other cancer drugs. Multiple myeloma is a form of blood cancer that primarily affects older adults and arises from […]